ELGX Endologix Inc

Endologix, Inc. (NASDAQ:ELGX), the developer and manufacturer of the Powerlink� System for the minimally invasive treatment of abdominal aortic aneurysms (AAA), today announced that President and Chief Executive Officer John McDermott will make presentations to the investment community at Stephens Fall Investment Conference, Tuesday, November 18, at 8:30 a.m. Eastern time. The conference will be held at The New York Palace Hotel in New York City. Interested investors may gain access to a live webcast of the presentation via the Internet by visiting the Company�s Web site at www.endologix.com. Please go to the Events & Presentations page on the Investor Relations section of the Web site. The presentation will be available and archived on the Web site for 30 days. About Endologix Endologix, Inc. develops and manufactures minimally invasive treatments for vascular diseases. Endologix's Powerlink System is an endoluminal stent graft for treating abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. Additional information can be found on Endologix�s Web site at www.endologix.com.